Edesa Biotech, Inc.
EDSA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $26 | $26 | $25 | $43 |
| Gross Profit | -$26 | -$26 | -$25 | -$43 |
| % Margin | – | – | – | – |
| R&D Expenses | $1,226 | $939 | $484 | $1,020 |
| G&A Expenses | $1,245 | $965 | $1,155 | $879 |
| SG&A Expenses | $1,245 | $965 | $1,155 | $879 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$26 | $0 | $0 | $0 |
| Operating Expenses | $2,444 | $1,904 | $1,639 | $1,899 |
| Operating Income | -$2,470 | -$1,904 | -$1,639 | -$1,899 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $242 | $154 | $49 | $281 |
| Pre-Tax Income | -$2,228 | -$1,749 | -$1,590 | -$1,617 |
| Tax Expense | $0 | $0 | $1 | $0 |
| Net Income | -$2,228 | -$1,749 | -$1,590 | -$1,617 |
| % Margin | – | – | – | – |
| EPS | -0.32 | -0.25 | -0.3 | -0.48 |
| % Growth | -28% | 16.7% | 37.5% | – |
| EPS Diluted | -0.32 | -0.25 | -0.3 | -0.48 |
| Weighted Avg Shares Out | 7,059 | 7,023 | 5,306 | 3,345 |
| Weighted Avg Shares Out Dil | 7,059 | 7,023 | 5,306 | 3,345 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $26 | $26 | $25 | $43 |
| EBITDA | -$2,197 | -$1,695 | -$1,565 | -$1,574 |
| % Margin | – | – | – | – |